Synthace

This company is included in Intelligence Lab

Synthace

Synthace logo

Website
http://synthace.com/

Founded
2011

Technologies

AI Companies (Drug Discovery)

Synthace is an interdisciplinary team of computer scientists, biologists, mathematicians, and chemists pioneering new ways of working digitally in biology. We’re backed by world-class investors and a growing collection of partners working on the hardware, software, and wetware required to truly industrialise biology’s potential.

synthetic biology life sciences

Articles Mentioning This Company

AI-driven Companies Creating Next Gen Infrastructure for Automated Drug Discovery

Companies Making Automated Drug Discovery a Reality

Data is king in modern biopharmaceutical research, and ability to generate massive amounts of quality biomedical data represents a tremendous research and business potential in the artificial intelligence (AI)-driven drug discovery realm. Challenges associated with big biological data, such as poor reproducibility, low accessibility, low standardization, etc, represent a considerable bottleneck …

AI in Synthetic Biology: From Gene Editing to Pathway Design

From Gene Editing to Pathway Design: How AI is Transforming Synthetic Biology

It is hard to overestimate the potential of biotechnology to address some of the most pressing challenges of the 21st century. These challenges include feeding a growing global population, improving healthcare and access to therapies, and mitigating the impacts of climate change.

Blending Biology and AI: Dr. Markus Gershater on the Future of Life Sciences

In the dynamic field of life sciences, both biological research and AI are coming together to alter our perspective on life at its most basic level. Dr. Markus Gershater, Co-founder and Chief Science Officer of Synthace, sheds light on the challenges and opportunities this union presents. Synthace, a UK-based no-code …